Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.05.012Source: DataRank Database

Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis is a research paper published in Journal of Allergy and Clinical Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 82 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access82 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 19.91)OA: hybridTopics (62)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jongmi Lee ORCID,Xuan Li ORCID,Hyun Soo Lee ORCID,Katherine Kim ORCID,Vasuma Chaparala

Live enrichment

PubMed:37271319 OpenAlex:https://openalex.org/W4379376898

National Institutes of Health

Grant: 5UL1TR001866-07

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

National Institutes of Health

Grant: 3K23AR080043-03S1

A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition

NIAMS NIH HHS

Grant: K23 AR080043

NCATS NIH HHS

Grant: UL1 TR001866

FWCI

19.91

Citation Percentile

1.0%

Influential Citations

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.jaci.2023.05.012

HYBRIDhttps://doi.org/10.1016/j.jaci.2023.05.012

publisherhttps://doi.org/10.1016/j.jaci.2023.05.012

publisherhttps://api.elsevier.com/content/article/PII:S0091674923007054?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674923007054?httpAccept=text/plain

Fields of Study

Hidradenitis Suppurativa and TreatmentsPsoriasis: Treatment and PathogenesisAcne and Rosacea Treatments and EffectsMedicineBiology03 medical and health sciences0302 clinical medicineHumansInterleukin-17Interleukin-6TranscriptomeLigandsInterleukin-11SkinPsoriasisKeratinocytesHidradenitis Suppurativa

MeSH Terms

HumansLigandsPsoriasisSkinKeratinocytesInterleukin-6Interleukin-11Hidradenitis SuppurativaInterleukin-17Transcriptome

Keywords

PsoriasisInterleukin 17Immune systemInterleukin 23BiologyImmunologyCytokineDendritic cellTranscriptomeReceptorCell biologyMolecular biologyChemistryGene expressionGeneGeneticsKeratinocytesIL-1R1610keratinocyteLigandsfibroblastsingle-cell RNA sequencingIL-17FIL-23IL-17AHumansSkinIL-1Interleukin-6Interleukin-17T celltype 17 T cellsInterleukin-11Hidradenitis Suppurativa

Sustainable Development Goals

SDG 0: Good health and well-being